A 4-Week, Double-blind, Placebo-controlled, Randomized, Multicenter, Crossover Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate hydrochloride] in Subjects with Parkinson's Disease and Excessive Sleep
Administered By
Awarded By
Contributors
- Scott, Burton Lasater Principal Investigator
Start/End
- May 15, 2017 - September 12, 2019